You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Aerosol Ionization Mass Spectrometer (AIMS)

    SBC: HEDGEFOG RESEARCH INC.            Topic: CBD212003

    There is an urgent need to rapidly test warfighters and their surrounding environment for disease-causing pathogens such as SARS-CoV-2. Existing methods for identifying pathogens in people usually require significant time and sample preparation. In addition, detecting pathogens such as SARS-CoV-2 in the air presents an even greater challenge. To meet the DoD need for field portable bioaerosol iden ...

    SBIR Phase I 2022 Department of DefenseOffice for Chemical and Biological Defense
  2. Field Portable Bioaerosol Identification with Miniaturized MALDI TOF MS  

    SBC: Zeteo Tech, Inc.            Topic: CBD212003

    Rapid, real-time bioaerosol identification is a key aspect in preventive measures for infectious disease outbreaks, e.g. SARS-CoV-2 or tuberculosis. Current screening tools are either non-specific, or are slow, costly, and reagent burdened. As with most respiratory pathogens, such diseases are primarily spread through human discharge of pathogen-containing droplets created by coughing, sneezing or ...

    SBIR Phase I 2022 Department of DefenseOffice for Chemical and Biological Defense
  3. Stable Antimicrobial Formulation of Scopolamine for Multi-dose Vial

    SBC: Clear Scientific, LLC            Topic: CBD212004

    Recent efforts to improve treatment for nerve agent poisoning include the development of a scopolamine hydrobromide injectable as an anticholinergic. A scopolamine injectable would add an extremely beneficial capability to the warfighter kit, however, incorporation of single-use vials represents a substantial logistical burden in the field. Co-formulation of the scopolamine injectable with a suita ...

    SBIR Phase I 2022 Department of DefenseOffice for Chemical and Biological Defense
  4. Formulation and analytical development of a multi-dose vial presentation of scopolamine hydrobromide trihydrate containing a antimicrobial preservatives (AMP)

    SBC: CMC PHARMACEUTICALS INC            Topic: CBD212004

    The Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical is developing scopolamine hydrobromide trihydrate (Scop-HBT) under the Improved Nerve Agent Treatment System - Centrally Acting program. Scop-HBT is an anticholinergic medical countermeasure that temporarily blocks severe or life-threatening muscarinic effects caused by organophosphorus nerve agent (OPNA) poisoni ...

    SBIR Phase I 2022 Department of DefenseOffice for Chemical and Biological Defense
  5. Multi Injection Vial Anti-contamination cap (MIVA-Cap)

    SBC: CHROMOLOGIC LLC            Topic: CBD212004

    To meet CBD’s need for a multi-dose formulation of scopolamine hydrobromide trihydrite ChromoLogic proposes to develop a vial add-on containing a self-decontamination cap with a self-healing material to eliminate evaporation and contamination risks through needle punctures in the septum. CL will also perform forced degradation and stability tests with a panel of preservatives to select optimal p ...

    SBIR Phase I 2022 Department of DefenseOffice for Chemical and Biological Defense
  6. Succor Combat Foam for Treatment of Dermal Injuries Caused by Sulfur Mustard

    SBC: CRITICAL INNOVATIONS LLC            Topic: CBD212005

    The Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical (JPM CBRN Medical) seeks to develop dermal dressing technologies that provide multiple advantages over current wound dressings for treating dermal injuries caused by sulfur mustard. Critical Innovations, Battelle's Biomedical Research Center, and NDA Partners, with consultants Captain David Tanen, MD, FAAEM, FACM ...

    SBIR Phase I 2022 Department of DefenseOffice for Chemical and Biological Defense
  7. Ruggedized Spray on Antimicrobial Wound Dressing for Treatment of Multiple Sulfur Mustard-Induced Dermal Injuries in Theater to Mitigate Infection, Pain and Promote Healing

    SBC: KERICURE INC            Topic: CBD212005

    Field Shield Wound Dressing (FSWD) is a novel wound dressing that takes an innovative approach to addressing major wounds, both in prolonged field care and throughout the continuum of care. It is the first wound dressing to combine an effective broad spectrum antimicrobial (nanosilver) with a local anesthetic (lidocaine) in a simple to apply point-and-spray wound dressing. A patented polyacrylate ...

    SBIR Phase I 2022 Department of DefenseOffice for Chemical and Biological Defense
  8. Development of novel Small Molecule Antiviral Endocytosis Inhibition pathway

    SBC: FABRICO TECHNOLOGY, INC.            Topic: CBD212006

    Fabrico Technology, Professor Kevin Dalby, the Johnson & Johnson Centennial Professor of Chemical Biology & Medicinal Chemistry, and Dr. Tamer Kaoud, Research Assistant Professor of Chemical Biology & Medicinal Chemistry, College of Pharmacy, the University of Texas at Austin (UT), propose to develop and discover a new family of a small molecule(s) that increases the endosomal pH resulting in inhi ...

    SBIR Phase I 2022 Department of DefenseOffice for Chemical and Biological Defense
  9. DNA Aptamers for Passive Immunity Against Bunyaviruses

    SBC: NANOHMICS INC            Topic: CBD212006

    Aptamers are oligonucleotides that bind like antibodies to envelope and other viral proteins to block or inhibit viral host cell entry and replication for passive immunity until a patient can mount an effective immune response. In Phase I, Nanohmics proposes to test existing DNA aptamers against Crimean Congo Hemorrhagic Fever envelope epitopes funded by a previous SBIR Phase II contract W81XWH-09 ...

    SBIR Phase I 2022 Department of DefenseOffice for Chemical and Biological Defense
  10. Surface-Enhanced Raman Scattering Substrate

    SBC: LYNNTECH INC.            Topic: CBD213001

    Raman spectroscopy has proven to be a reliable field deployable detection technique for assessing chemical threats, including chemical warfare agents, energetic materials, and illicit narcotics. Military and Homeland Security agencies commonly utilize various portable Raman systems in sensitive site exploitation, checkpoint scenarios, and to determine hazardous content on surfaces or containers. E ...

    SBIR Phase I 2022 Department of DefenseOffice for Chemical and Biological Defense
US Flag An Official Website of the United States Government